Andrew M Scott

Loading... 2 0 20 0 false
Credit Name
Andrew M Scott
Full Name
Scott, Andrew M
 
Title
Prof
 
264-Scott.jpg picture
 
Personal Site
https://www.onjcancercentre.org/
 
Twitter
Biography
We love promoting your work, however you know best what to say. Please login and update your profile or let us know what you would like to say about yourself!
 
Loading... 3 0 20 0 false

Publications

Refined By:
Fulltext:  No Fulltext
Author:  Lee, Fook-Thean
Subject:  Humans

Results 1-20 of 24 (Search time: 0.02 seconds).

Publication YearTitleAuthor(s)
117-Sep-2013Molecular imaging of death receptor 5 occupancy and saturation kinetics in vivo by humanized monoclonal antibody CS-1008.Burvenich, Ingrid J G; Lee, Fook-Thean; Cartwright, Glenn A; O'Keefe, Graeme J; Makris, Dahna; Cao, Diana; Gong, Sylvia J; Chueh, Anderly C; Mariadason, John M ; Brechbiel, Martin W; Beckman, Robert A; Fujiwara, Kosaku; von Roemeling, Reinhard; Scott, Andrew M 
213-Oct-2009Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers.Herbertson, Rebecca A; Tebbutt, Niall C ; Lee, Fook-Thean; MacFarlane, David J; Chappell, Bridget; Micallef, Noel; Lee, Sze-Ting; Saunder, Timothy; Hopkins, Wendie; Smyth, Fiona E; Wyld, David K; Bellen, John; Sonnichsen, Daryl S; Brechbiel, Martin W; Murone, Carmel ; Scott, Andrew M 
312-Jun-2009Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.Lawrentschuk, Nathan; Lee, Fook-Thean; Jones, Gareth; Rigopoulos, Angela; Mountain, Angela; O'Keefe, Graeme J; Papenfuss, Anthony T; Bolton, Damien M ; Davis, Ian D; Scott, Andrew M 
41-Jan-2009Therapeutic efficacy of 177Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.Kelly, Marcus P; Lee, Sze Ting ; Lee, Fook-Thean; Smyth, Fiona E; Davis, Ian D; Brechbiel, Martin W; Scott, Andrew M 
51-Aug-2008Tumor targeting by a multivalent single-chain Fv (scFv) anti-Lewis Y antibody construct.Kelly, Marcus P; Lee, Fook-Thean; Tahtis, Kiki; Power, David Anthony; Smyth, Fiona E; Brechbiel, Martin W; Hudson, Peter J; Scott, Andrew M 
61-Dec-2007Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: a novel anti-epidermal growth factor receptor antibody.Perera, Rushika M; Zoncu, Roberto; Johns, Terrance G; Pypaert, Marc; Lee, Fook-Thean; Mellman, Ira; Old, Lloyd J; Toomre, Derek K; Scott, Andrew M 
715-Sep-2007Radioimmunotherapy with alpha-particle emitting 213Bi-C-functionalized trans-cyclohexyl-diethylenetriaminepentaacetic acid-humanized 3S193 is enhanced by combination with paclitaxel chemotherapy.Kelly, Marcus P; Lee, Fook-Thean; Tahtis, Kiki; Smyth, Fiona E; Brechbiel, Martin W; Scott, Andrew M 
81-Jun-2007A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen.Scott, Andrew M ; Tebbutt, Niall C ; Lee, Fook-Thean; Cavicchiolo, Tina; Liu, Zhanqi; Gill, Sanjeev; Poon, Aurora M T ; Hopkins, Wendie; Smyth, Fiona E; Murone, Carmel ; MacGregor, Duncan; Papenfuss, Anthony T; Chappell, Bridget; Saunder, Timothy H; Brechbiel, Martin W; Davis, Ian D; Murphy, Roger; Chong, Geoffrey ; Hoffman, Eric W; Old, Lloyd J
921-Jun-2006Xenografting tumour beneath the renal capsule using modern surgical equipment.Lawrentschuk, Nathan; Rigopoulos, Angela; Lee, Fook-Thean; Davis, Ian D; Scott, Andrew M ; Bolton, Damien M 
101-Apr-2006Enhanced efficacy of 90Y-radiolabeled anti-Lewis Y humanized monoclonal antibody hu3S193 and paclitaxel combined-modality radioimmunotherapy in a breast cancer model.Kelly, Marcus P; Lee, Fook-Thean; Smyth, Fiona E; Brechbiel, Martin W; Scott, Andrew M 
111-Oct-2005Enhanced efficacy of radioimmunotherapy with 90Y-CHX-A''-DTPA-hu3S193 by inhibition of epidermal growth factor receptor (EGFR) signaling with EGFR tyrosine kinase inhibitor AG1478.Lee, Fook-Thean; Mountain, Angela J; Kelly, Marcus P; Hall, Cathrine; Rigopoulos, Angela; Johns, Terrance G; Smyth, Fiona E; Brechbiel, Martin W; Nice, Edouard C; Burgess, Antony W; Scott, Andrew M 
1228-Mar-2005Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR.Panousis, C; Rayzman, V M; Johns, T G; Renner, C; Liu, Z; Cartwright, Glenn A; Lee, Fook-Thean; Wang, D; Gan, Hui K ; Cao, D; Kypridis, A; Smyth, Fiona E; Brechbiel, Martin W; Burgess, Antony W; Old, Lloyd J; Scott, Andrew M 
1322-Feb-2005Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma.Scott, Andrew M ; Liu, Zhanqi; Murone, Carmel ; Johns, Terrance G; MacGregor, Duncan; Smyth, Fiona E; Lee, Fook-Thean; Cebon, Jonathan S ; Davis, Ian D; Hopkins, Wendie; Mountain, Angela J; Rigopoulos, Angela; Hanai, Nobuo; Old, Lloyd J
141-Aug-2003Immuno-PET for tumor targeting.Lee, Fook-Thean; Scott, Andrew M 
151-Aug-2003Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model.Tahtis, Kiki; Lee, Fook-Thean; Wheatley, Jennifer M; Garin-Chesa, Pilar; Park, John E; Smyth, Fiona E; Obata, Yuichi; Stockert, Elisabeth; Hall, Cathrine M; Old, Lloyd J; Rettig, Wolfgang J; Scott, Andrew M 
161-Jul-2003Targeting primary human Ph(+) B-cell precursor leukemia-engrafted SCID mice using radiolabeled anti-CD19 monoclonal antibodies.Mitchell, Paul L R ; Lee, Fook-Thean; Hall, Cathrine; Rigopoulos, Angela; Smyth, Fiona E; Hekman, Anne-Marie; van Schijndel, Gijs M; Powles, Ray; Brechbiel, Martin W; Scott, Andrew M 
171-May-2003A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.Scott, Andrew M ; Wiseman, Greg; Welt, Sydney; Adjei, Alex; Lee, Fook-Thean; Hopkins, Wendie; Divgi, Chaitan R; Hanson, Lorelei H; Mitchell, Paul L R ; Gansen, Denise N; Larson, Steven M; Ingle, James N; Hoffman, Eric W; Tanswell, Paul; Ritter, Gerd; Cohen, Leonard S; Bette, Peter; Arvay, Lisa; Amelsberg, Andree; Vlock, Dan; Rettig, Wolfgang J; Old, Lloyd J
187-Oct-2002Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.Liu, Zhanqi; Lee, Fook-Thean; Hanai, Nobuo; Smyth, Fiona E; Burgess, Antony W; Old, Lloyd J; Scott, Andrew M 
191-Oct-2001Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial.Scott, Andrew M ; Lee, Fook-Thean; Hopkins, Wendie; Cebon, Jonathan S ; Wheatley, J M; Liu, Z; Smyth, Fiona E; Murone, Carmel ; Sturrock, S; MacGregor, Duncan; Hanai, N; Inoue, K; Yamasaki, M; Brechbiel, Martin W; Davis, Ian D; Murphy, R; Hannah, A; Lim-Joon, M; Chan, T; Chong, Geoffrey ; Ritter, G; Hoffman, E W; Burgess, Antony W; Old, Lloyd J
201-Jun-2001Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts.Lee, Fook-Thean; Rigopoulos, Angela; Hall, C; Clarke, K; Cody, S H; Smyth, Fiona E; Liu, Z; Brechbiel, Martin W; Hanai, N; Nice, Edouard C; Catimel, B; Burgess, Antony W; Welt, S; Ritter, G; Old, Lloyd J; Scott, Andrew M